ivacaftor
SpainDrugs containing this active substance
-
It is used to help lung cells function better in patients with cystic fibrosis (CF) who have at least one CFTR gene mutation that responds to treatment. It helps improve breathing and lung function and may facilitate weight gain.
Form: tablets, film-coated
Active substance Dosage ivacaftor 37,5 mg tezacaftor 25 mg elexacaftor 50 mg Manufacturer: Vertex Pharmaceuticals (Ireland) Limited
-
It helps lung cells function better in some patients with cystic fibrosis (CF), improving breathing and helping to make weight gain easier.
Form: granules, in sachet
Active substance Dosage ivacaftor 60 mg tezacaftor 40 mg elexacaftor 80 mg Manufacturer: Vertex Pharmaceuticals (Ireland) Limited
-
It is used to help lung cells function better in patients with cystic fibrosis (CF) who have at least one CFTR gene mutation that responds to the medication.
Form: tablets, film-coated
Active substance Dosage tezacaftor 50 mg ivacaftor 75 mg elexacaftor 100 mg Manufacturer: Vertex Pharmaceuticals (Ireland) Limited
-
It is used to help lung cells function better in some patients with cystic fibrosis (CF) who have at least one mutation in the CFTR gene that responds to the medication.
Form: granules, in sachet
Active substance Dosage ivacaftor 75 mg tezacaftor 50 mg elexacaftor 100 mg Manufacturer: Vertex Pharmaceuticals (Ireland) Limited
-
It is used to treat patients with cystic fibrosis (CF) who have specific mutations in the CFTR gene. It helps abnormal proteins function better to improve chloride movement in the cells.
Form: tablets, film-coated
Active substance Dosage ivacaftor 150 mg Manufacturer: Vertex Pharmaceuticals (Ireland) Limited
-
It is used to treat infants and children (from 4 months of age onwards) with cystic fibrosis who have certain specific mutations in the CFTR gene. It can be used alone or in combination with other medications depending on age and the type of mutation.
Form: granules
Active substance Dosage ivacaftor 25 mg Manufacturer: Vertex Pharmaceuticals (Ireland) Limited
-
It is used for the treatment of infants and children with cystic fibrosis (CF) who have certain specific mutations in the CFTR gene. It can be used alone or in combination with other medications depending on age and the type of mutation.
Form: granules, in sachet
Active substance Dosage ivacaftor 50 mg Manufacturer: Vertex Pharmaceuticals (Ireland) Limited
-
It is used to treat infants and children with cystic fibrosis (CF) who have certain specific mutations in the CFTR gene. It can be used alone or in combination with other medications depending on age and the type of mutation.
Form: granules
Active substance Dosage ivacaftor 59,5 mg Manufacturer: Vertex Pharmaceuticals (Ireland) Limited
-
It is used to treat patients with cystic fibrosis (CF) who have certain specific mutations in the CFTR gene, either as a standalone treatment or in combination with other medications.
Form: tablets, film-coated
Active substance Dosage ivacaftor 93,75 mg Manufacturer: Vertex Pharmaceuticals (Ireland) Limited
-
It is used for the treatment of infants and children with cystic fibrosis (CF) who have certain specific mutations in the CFTR gene. It can be used alone or in combination with other medications depending on age and mutation.
Form: granules, in sachet
Active substance Dosage ivacaftor 75 mg Manufacturer: Vertex Pharmaceuticals (Ireland) Limited
-
It is used for the long-term treatment of cystic fibrosis (CF) in patients 6 years of age or older who have a specific mutation called F508del in the CFTR gene.
Form: tablets, film-coated
Active substance Dosage lumacaftor 100 mg ivacaftor 125 mg Manufacturer: Vertex Pharmaceuticals (Ireland) Limited
-
It is used for the long-term treatment of cystic fibrosis (CF) in patients 1 year of age or older who have a specific mutation called F508del in the CFTR gene.
Form: granules
Active substance Dosage lumacaftor 100 mg ivacaftor 125 mg Manufacturer: Vertex Pharmaceuticals (Ireland) Limited
-
It is used for the long-term treatment of cystic fibrosis (CF) in patients 1 year of age or older who have a specific mutation called F508del in the CFTR gene.
Form: granules
Active substance Dosage lumacaftor 150 mg ivacaftor 188 mg Manufacturer: Vertex Pharmaceuticals (Ireland) Limited
-
It is used for the long-term treatment of cystic fibrosis (CF) in patients 6 years of age and older who have a specific mutation called F508del in the CFTR gene.
Form: tablets, film-coated
Active substance Dosage ivacaftor 125 mg lumacaftor 200 mg Manufacturer: Vertex Pharmaceuticals (Ireland) Limited
-
It is used for the long-term treatment of cystic fibrosis (CF) in patients 1 year of age or older who have a specific mutation called F508del in the CFTR gene.
Form: granules
Active substance Dosage lumacaftor 75 mg ivacaftor 94 mg Manufacturer: Vertex Pharmaceuticals (Ireland) Limited
-
It is used for the long-term treatment of patients aged 6 years or older with cystic fibrosis (CF) who have certain genetic mutations. It helps improve lung function and may facilitate weight gain.
Form: tablets, film-coated
Active substance Dosage tezacaftor 100 mg ivacaftor 150 mg Manufacturer: Vertex Pharmaceuticals (Ireland) Limited
-
It is used for the long-term treatment of patients aged 6 years or older with cystic fibrosis (CF) who have certain genetic mutations. It helps improve lung function and may facilitate weight gain.
Form: tablets, film-coated
Active substance Dosage tezacaftor 50 mg ivacaftor 75 mg Manufacturer: Vertex Pharmaceuticals (Ireland) Limited